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Summary 
Dendritic cells form a system of antigen presenting cells that are specialized to stimulate  T 
lymphocytes, including quiescent T cells. The lineage of dendritic cells is not fully characterized, 
although prior studies have shown that growth and differentiation are controlled by cytokines, 
particularly granulocyte/macrophage colony-stimulating factor (GM-CSF). To further elucidate 
the nature and control of the dendritic cell lineage, we have studied the expression of specific 
cytokine receptors. Su//ident numbers of dendritic cells were purified from spleen and skin to 
do quantitative binding studies with radiolabeled M-CSF, GM-CSF, and interleukin 1 (IL-1). 
To verify the nonlymphoid nature of dendritic cells, we made an initial search for rearrangements 
in T  call receptor and immunoglobulin genes and none were found. M-CSF binding sites, a 
property of mononuclear phagocytes,  also were absent.  In contrast,  GM-CSF  receptors were 
abundant on mature dendritic ceils, with ",,3,000 binding sites/cell with a single Ka of 500-1,000 
pM. Substantial numbers of high affinity (<100 pM) IL-1 binding sites were identified as well; 
cultured epidermal dendritic cells (i.e., epidermal Langerhans cells) had 500/cell and spleen dendritic 
cells '~70/cell.  Cross-linking approaches showed the 80-kD species that is expected of high-affinity 
type 1 IL-1 receptor. Anti-type 1 IL-1 receptor (R) mAbs also visualized these receptors by flow 
cytometry on freshly isolated epidermal dendritic cells. These results provide new evidence that 
dendritic cells  represent a ~tiation  pathway distinct from lymphocytes and monocytes. Together 
with recent  findings on the effects of IL-1 and GM-CSF  on epidermal dendritic cells in situ 
(see Results and Discussion), the data lead to a proposal whereby IL-1 signals IL-1R to upregulate 
GM-CSF receptors and thereby, the observed responsiveness of dendritic cells to GM-CSF for 
growth, viability,  and function. 
radually, mechanisms are being identified to explain how 
dendritic cells  (DC) 1 operate  in  situ  to  initiate  T 
cell-dependent immune responses  (for  review  see  1,  2). 
Epi&~mal dendritic ceils (Langerhans  cells, [LC]) have provided 
a good deal of information (for review see 3, 4). These cells 
are equipped to acquire antigen in the skin, to transport the 
antigen to lymphoid organs,  and there to sensitize T  cells 
most likely in the T cell areas. IL-1 can initiate this stepwise 
series of DC functions in situ (5, 6). GM-CSF likely plays 
a subsequent role in the development and maturation of im- 
munostimulatory functions (7, 8). Other populations of DC, 
1 Abbreviations used in this paper: dl, cultured  for 1 day; d3, cultured  for 
3 days; DC, dendritic  cells; EC, epidermal cells; hlL-lra,  human IL-1 
receptor antagonist;  LC, Lang~rhans cells; K, receptor. 
such as those in rat lung (9, 10) and human blood (11), like- 
wise develop their typical features and functions in response 
to cytokines. 
It follows that the responsiveness of DC to cytokines, like 
IL-1 (7, 12) and GM-CSF (7, 13), could underlie early events 
in the development ofT call immunity. We now have looked 
for the frequency and types of cytokine receptors on DC in 
a nonlymphoid tissue, skin, and in the lymphoid organ, spleen. 
This topic has not previously been approached directly, in 
part because the isolation  of the required numbers of DC 
is not straightforward. We report that mature DC lack M-CSF 
binding sites, but express relatively high levels  of a single class 
each of GM-CSF  and IL-1 binding sites. These and other 
findings are used to propose  that DC are a nonlymphoid, 
nonmacrophage lineage that is mobilized by the sequential 
action of IL-1 and GM-CSF  on their respective receptors. 
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Mice.  Specific  pathogen-free BALB/c (H-2  a) and C3H/He (H- 
2 k) mice (6-12 wk old of both sexes) were obtained from Charles 
River Wiga GmbH (Sulzfeld, Germany). We used mainly BALB/c 
mice, but pilot experiments were also performed with C3H/He 
mice, and yielded comparable results. 
Culture Medium.  RPMI 1640 supplemented  with  10% FCS 
(56~  0.5 h; Seromed, Biochrom KG, Berlin, Germany), 1 mM 
t-glutamine,  5  x  10-5 2-ME, and 50 ~tg/ml gentamicin  sulfate. 
Spleen DC.  DC were prepared from the low density fractions 
of collagenase-treated spleens. After overnight culture the nonad- 
herent cells were harvested and depleted of residual macrophages 
and B ceils by rosetting with EA to provide an EA- DC fraction 
of >90% purity as described (14). In most experiments the low 
density fractions were pretreated with anti-B220 (TIB-146; Amer- 
ican Type Culture Collection [ATCC], R.ockville, MD) and anti- 
Thy 1 (TIB 99, ATCC) mAbs plus C' to reduce the number of 
B and T ]ymphocytes, respectively.  The purity of the final DC prep- 
aration  (yield: 0.3  x  106/spleen) was then  consistently  at least 
95% as determined by cytology and flow cytometry analysis of rele- 
vant surface markers (14). 
Epidermal LC.  Epidermal  cell (EC)  suspensions (containing 
1-3% LC) were prepared from ear skin by exposure to 1% trypsin 
(Cat.  No.  16-893-49; Flow Laboratories, Irvine, Scotland),  and 
treated with anti-Thy 1-mAb and rabbit C' followed  by a brief trypsin 
exposure (0.125%, 10 min, 37~  to remove dead cells exactly as 
described (15). This treatment  removes most keratinocytes as well 
as the dendritic, ~//6 + Thy-l+ EC, and results in a viable (>90%) 
EC suspension containing  about 15% LC (15). To obtain d3 LC 
the anti-Thyl/C'-treated  EC were cultured  (20  x  106/100 mm 
petri dish) for 72 h exactly as described (16), and the nonadherent 
fractions floated on dense albumin colunms as described (15). These 
nonadherent low density cells contained most of the LC in the cul- 
ture and were 60-90% LC. For those experiments requiring more 
highly enriched LC, we enriched LC to >95% by a "mismatched" 
panning technique (15-17) from either fresh or nonadherent  frac- 
tions of 16-72 h cultured anti-Thy 1/C'-treated EC (yidd: 3-6  x 
104 fresh or cultured  LC/2 mouse ears). 
Th,/mocytes.  Thymic  lobes  were  thoroughly  teased, passed 
through  a metal sieve, and the resulting  thymic cell suspension 
filtered through a nylon mesh (Nitex 3-325-44; Tetko, Ehnsford, 
NY). 
Peritoneal Macrophages.  Peritoneal macrophages were exudate 
cells harvested by lavage using 10 ml of PBS 5-7 d after a single 
injection of 2 ml thioglycollate medium (yidd: 8-15  x  106 cells/ 
lavage). 
Cell Lines.  PAM 212, J774, and 70Z/3 lines were obtained from 
ATCC, the EL4-NOB1 cell line from the European Collection of 
Animal Cell Cultures  (ECACC;  Forton Down, Salisbury, UK). 
Adherent PAM 212 and J774 cells were harvested by exposure to 
0.5  mM EDTA in Ca  2+, Mg  2+  free PBS followed by vigorous 
pipetting. 
TCR Gene Rearrangement.  DNA was prepared according to 
standard techniques (18) by lysis of cells in 50 mM Tris-HC1 (pH 
8.0), 100 mM EDTA, 0.1% SDS buffer, followed by proteinase K 
digestion (0.5 mg/ml, 55~  overnight),  phenol and chloroform 
extractions and isopropanol precipitation,  digested with EcoRI, 
electrophoresed on a 0.7% agarose gel (5 ~tg DNA/lane), trans- 
ferred to ~" probe (Bio-Rad Laboratories GesmbH., Vienna, Aus- 
tria) by alkaline blotting (19), and then hybridized as described (20) 
using  the following  probes which were 3zP-labeled by random 
priming (21): (a) J~l, a 500-bp PvulI/PstI fragment including the 
Jr  coding region (22) and Cot, a 700-bp NcoI fragment from a 
Cot cDNA clone (23) probes; or (b) a C'y1 probe (20). Liver and 
AKK thymoma 110 (24) DNA served as positive and negative con- 
trois, respectively. 
Ig C,  ene Rearrangement.  DNA was isolated from DC, LC, the 
Avison B cell line (serving as a positive control) (provided by Dr. 
C. Peschd, Gutenberg University, Mainz, Germany) and BALB/c 
kidney (germ line control), digested with EcoRI, electrophoresed, 
and then transferred onto nylon membranes and finally hybridized 
employing a 32P-hbeled  Jll probe (25) (kindly provided by Dr. C. 
Peschel). The Jll probe spans the Jm and J,4 region of the C/~ 
flanking sequences in the mouse Ig/t genes. 
I2sI-GM-CSF Binding Assays.  Radiolabeling of carrier-free re- 
combinant  muGM-CSF  and equilibrium binding  assays were es- 
sentially done as previously described (26, 27). In brief, purified 
rmu  GM-CSF  (specific activity  >4  x  107 U/mg protein;  Im- 
munex Co., Seattle, WA) was radiolabeled using the Enzymobead 
radioiodination reagent (Bio-Rad hboratories) to a specik activity 
of 60,000  cpm/ng  (~*  1.1  x  10  is  cpm/mmol),  nSI-GM-CSF 
lacked high molecular weight aggregates, and retained >90% of 
its biological activity as assessed by survival of purified LC after 
3 d of culture (7, 8). For binding  assays 106 DC, 106 LC, and 2 
x  10  ~ J774 cells each were washed three  times in cold binding 
buffer (FBS, 2% BSA, 20 mM Hepes buffer, pH 7.2, 0.2% sodium 
azide), and resuspended in 100 #1 binding buffer containing  the 
specified amounts  of nSI-GM-CSF with  or without  a 50-fold 
molar e~.ess of  u~abel~ GM-CSF to determine nonspecific  binding. 
Incubations were carried out in 96-well flexible assay phtes (Falcon 
Labware, Oxnard, CA) at 37~  for 45 rain (this incubation time 
was found in pilot experiments to achieve binding  equilibrium). 
Cell suspensions were then layered atop 200 #1 of a phthalate oil 
mixture [1.5 parts of dibutylphthahte, 1 part of bis(2-ethylhexyl)- 
phthalate; Sigma GmbH, Deisenhofen, Germany] precooled to 4~ 
in 400 #1 polyethylene centrifuge tubes. Samples were centrifuged 
for 2 mix at 11,000 g. Cell-bound  (cell pellet) and free (superna- 
tant) nsI-GM-CSF was quantitated using a gamma counter (LKB- 
Wallac, Turku, Finland). Equilibrium binding data were analyzed 
according to the method of Scatchard (28) and by computerized 
linear regression analysis. 
12SI-M-CSF  Binding Assay~  Purified  carrier-free human recom- 
binant  M-CSF  produced by transfected CHO ceils (1.9  x  10  ~ 
U/mg, courtesy of Dr. Steven Clark, Genetics Institute, Cambridge, 
MA) was radiohbeled using the Enzymobead radioiodination re- 
agent  (Bio-Red Laboratories GesmbH.) to a specific activity of 
80,000 cpm/ng (=  1.1  x  10  ~s cpm/mmol) (29). 12SI-M-CSF re- 
tained >90% of its biological activity as determined by a mouse 
bone marrow proliferation assay. Binding  assays were performed 
as described above for GM-CSF except that incubation was for 120 
min, and all steps were strictly performed on ice to avoid ligand- 
induced receptor internalization (29). In pilot experiments 1/,g/ml 
polymyxin B was included to neutralize any contaminating  LPS 
(30) with identical results. 
'25I-IL1 Binding Assays and A~inity Cross-linking.  To study IL-1 
receptors (K) on DC, dl and d3 LC, and control cells (i.e., the 
EL4-NOB1 murine T cell lymphoma cell line expressing the type 
1 IL-1R and the 70Z/3 murine pre-B lymphoma cell line that ex- 
presses the type 2 IL-1K) (31, 32) we performed binding  assays 
essentially as described (33). In brief,  after two washes in cold 
binding  buffer  (see above) samples of cells (1-5  x  106 each re- 
suspended in 100 #1) were incubated (2 h, 4~  permanent shaking) 
in increasing concentrations  of nsI-Ib1ot  or/3 (2,000 Ci/mmol 
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proliferation assay, purchased from Amersham International, Little 
Chalfort,  UK) with or without a 50- or 100-fold molar ear.ess of 
recombinant human IL-lfl (British Biotechnology, Abingdon, UK). 
In pilot experiments we also prewashed cells  in pH 3.0 glycine buffer 
to remove any prebound  IL-1 (31), but  this  procedure  did  not 
markedly change results, and was, therefore,  omitted in further 
binding assays. In selected experiments blocking mAbs to the type 
1 IblK either mAb 1593-01 (obtained from Genzyme Corp., Cam- 
bridge, MA) or mAb M15 (34) or human recombinant  IL-1K an- 
tagonist (kindly provided by Dr. A. Steinkasserer, MKC Immuno- 
chemistry  Unit, University  of Oxford, Oxford, UK, [35]) were 
added 30 rain before the addition of IL-1. Duplicate aliquots of cells 
with bound IL-1 were separated from free 1D1 by centrifugation 
through a phthalate oil mixture,  and equilibrium data analyzed ac- 
cording  to  Scatchard (28)  as described  above for  lzSI-GM-CSF 
binding.  For  affanity cross-linking  of tzsI-II..13 we followed the 
protocol described by Dower et  al.  (33).  In  short,  2-3  x  106 
highly  enriched  dl  or d3 LC,  5  x  106 DC, EL 4-NOB1, and 
70Z/3 cells were incubated in binding medium for 2 h at 4~  with 
10 -9 M lzsI-IL-lfl in the presence or absence of a 50-fold molar 
excess  of  unlabded  IL-lfl.  After  washes,  cell  samples were 
resuspended in 100/zl PBS and 2 #1 disuccinimidyl suberate (DDS; 
Pierce Chemical, Rockford, IL) solution (50 mg/ml DMSO) was 
added. Samples were incubated for 30 min at room temperature, 
then washed, and finally resuspended in 20--50 #I PBS containing 
1% Triton X-100 and 2 mmol/liter PMSF to ~t  proteolytic 
degradation.  After a 15-min detergent  extraction and centrifuga- 
tion to remove nuclei and debris, 15-40 #1 supernatant was taken 
off  and 2-4/zl aliquots were analyzed  by SDS/PAGE under reducing 
conditions  employing  a 10-15%  gradient  or 7.5% homogenous 
gels and a Phast System (Pharmacia LKB, Uppsah,  Sweden). 
Cytofluorograp~ .A~ly.~ of Cytokine Receptors.  We used cyto- 
fluorography (FACScan  |  Becton Dickinson & Co., Mountain View, 
CA) of viable, propidium  iodide exchding cells to detect surface 
expression  of cytokine  receptors.  For  the  detection  of M-CSF 
receptors spleen DC, d3 I.C, and J774 cells (this macrophage cell 
line served as a positive control) were incubated (40 min each on 
ice) in goat anti-CSF-1 R  antiserum  (diluted  1:200 in PBS, 1% 
BSA, 0.2% sodium-azide) (kindly provided by Dr. E. K. Stanley, 
Albert Einstein College of Medicine, Bronx,  New York) or con- 
trol normal goat serum, followed by biotinyhted swine anti-goat 
IgG (Tago, Inc., Burlingame,  CA), and finally FITC-streptavidin 
diluted 1:500 (Amersham International).  For staining of the IblR. 
type 1,  the cells were incubated  with  three  different rat  IgG2a 
anti-mouse ID1R. type 1 mAbs (MS [34], M15 [34], or 1593-01 
[obtained from Genzyme Corp.] at 10 #g/ml followed by FITC- 
conjugated mouse anti-rat Ig mAb [Cat. no. 605540; Boehringer 
Mannheim Corp., Indianapolis, IN]). To identify BALB/c LC this 
incubation  sequence was extended by rat Ig to block free anti-rat 
Ig binding  sites, biotinylated  anti-I-A  b,a mAb (clone B21-2, rat 
IgG2b,  TIB 229 from ATCC),  and,  finally, streptavidin-phyco- 
erythrin  (Dianova, Hamburg, Germany). To stain I.C of C3H/He 
mice  we  used  murine  anti-I-E ~,a  mAb  (clone  14-4-4S, mouse 
IgG2a,  HB32 from ATCC) followed by phycoethrin-conjugated 
donkey anti-mouse Ig (Cat.  no.  715-116-151; Jackson  Immuno- 
Research Laboratories, Inc.,  West Grove, PA). 
Results  and  Discussion 
TCR and Ig Genes Are in Germline State in Spleen DC As 
WellAs LC.  Despite the accumulating evidence (including 
single cell  assays) that  DC are myeloid cells  (1,  2,  36, 37), 
we considered the formal possibility that DC might be related 
to lymphocytes. For example several T  cell-assodated mole- 
cules (CD1, CD4, CDS, and CD8) are expressed by certain 
human and murine DC subsets (1, 2,  11, 38-40) and Short- 
man et al.  (41) identified a population of early murine pre- 
cursors that  gave rise to both DC  and T  ceUs (but not B 
cells or phagocytes) when transferred into irradiated thymi. 
When we studied lymphoid DC (highly enriched from spleen 
by a  method  [40]  ensuring  recovery of loosely as  well as 
more strongly tissue-bound DC) as well as fresh or cultured 
LC (a homogenous and well-characterized subset of nonlym- 
phoid tissue DC) (3, 4) we found no evidence for a rearrange- 
ment of either TCR or Ig genes (see Fig.  1, A  and B  and 
Fig.  2) supplementing  the observation by Shortman  et  al. 
(40)  that  thymic  DC  have TCR  in  germline.  These  data 
show, therefore, that DC would have to deviate before lym- 
phocyte gene rearrangement from a putative common DC/T 
cell precursor  (41). 
Spleen DC and I.C, Express a Single Class of Receptors  for 
GM-CSF.  We performed three complete equilibrium binding 
experiments with BALB/c DC and d3 LC, and, as a positive 
control, the J774 macrophage line.  Pilot experiments using 
DC and LC prepared from C3H/He mice yielded comparable 
results.  Scatchard analysis of the binding data revealed a single 
class of GM-CSF-R on DC as well as LC (Fig.  3) with  a 
Ka in the range of 500-1,000 pM, i.e.,  an affinity similar to 
that seen on other cell types including mydoid ones (26, 27, 
42). About 3,000 specific binding sites per DC or LC were 
found (see Table 1).  This is a relatively large number  and, 
using J774 as a reference for comparison with published 
bYata, would translate into  two to three times  the receptor 
Figure  1.  Southern blot analysis of TCR gene status. 5 /~g EcolLl 
digested DNA samples/lane  in AKK thymoma  cells (lane 1), d3 LC (lane 
2), spleen  DC (lane  3), and BALB/c  liver (lane  4). (.4)  J81 and Cot probes: 
both probes were  hybridized at the same time to give an internal control 
for the amount of DNA. In the TCR ot/fl expressing AKK thymoma 
cells the J81 band is absent as the/~ locus is obligatorily  deleted during 
VJot rearrangements (63). The ratio of J81 to Cot bands stays, however, 
constant in LC, DC, and BALB/c  live~  (- germline  control) samples  indi- 
cating that no TCR rearrangement has occurred. (B) C~ probe: I.C and 
DC show the same three bands as the BALB/c  live~ germline control, 
whereas a C3, rearrangement is obvious in the AKK thymoma cells. 
Horizontal bars indicate  DNA size  markers (21, 9.4, 6.6, and 4.3 kb from 
top to bottom). 
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ysis oflg gene status. 5/~g EcoILl 
digested DNA in Avison Bcen 
line (hne I), spleen DC (lane 2), 
d3  LC  (lane 3),  and  BALB/c 
kidney  (lane 4)  using the  Jll 
probe which spans over the Jm 
and  JH4  region  of  the  C/~ 
flanking sequences  in the BALB/c 
germ line JH region. Note that 
an Ig gene rearrangement is de- 
tectabh in the Avison  B cell line, 
but not in DC, LC, or the kidney 
(- germllne  control)  DNA. Hor- 
izontal bars indicate DNA size 
markers (7, 6, 5, 4, 3, 2, 1.6, 1 
kb from top to bottom). 
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Figure  3.  Equilibrium binding  of  12SI-GM-CSF. Highly  enriched 
BALB/c d3 LC (A and A"), spleen DC (B and B'), or J774 cells (C and 
C") were incubated for 45 min at 37~  with various concentrations of 
rmu 12SI-GM-CSF  (see Materials and Methods for experimental details). 
A, B, and C show specific  binding data; A', B", and C" show a Scatchard 
representation of the specific  binding data replotted from A, B, and C, 
respectively. Kd, dissociation constant, B max, maximum binding. 
Table  1.  Binding Characteristics of rrau 12SI-GM-CSF to Murine 
Cultured LC, Spleen DC,  and J774 Cells 
Cell type  GM-CSF-R  Kd 
nura~/cell  pM 
d3 LC  3,248  (+  168)  745  (+  198) 
DC  2,644  (_+  174)  544  (_+  65) 
J774 macrophage line  858  (+  41)  1,170 (_+  244) 
Data represent the mean ( •  SD) of three independent equilibrium binding 
assays performed as outlined under Materials and Methods. DC and LC 
were prepared from BALB/mice, but pilot experiments using C3H/He 
LC and DC yidded comparable results. 
number  reported  for  peritoneal  exudate  or  normal  bone 
marrow cells.  3,000 binding sites would be comparable to 
receptor numbers found on purified granulocyte/macrophage 
progenitor cells (26,  27, 42).  With regard to the detection 
of solely a single type of receptors on the trace population 
of DC and LC we could not use >2  x  106 cells/assay  point, 
and might,  therefore,  have missed a  small subset  of addi- 
tional receptors with lower or higher affinity. The observa- 
tion that ~60 pM GM-CSF is needed to maintain the via- 
bility of LC and DC is in congruence with the expression 
of a single dass of GM-CSF-R on LC and DC. It is known 
that a subset of occupied receptors, and, thus, a concentra- 
tion several orders of magnitude below the Ka is sufficient 
for maximal biological activity (27). We were unable to detect 
GM-CSF  receptors  on  freshly prepared  LC.  This  finding 
is,  however, inconclusive as  trypsin exposure is  needed for 
preparation  of EC  and trypsin removes GM-CSF-binding 
sites on cultured LC (data not  shown). 
Recent single cell assays have shown that DC, macrophages, 
and granulocytes share a common progenitor (36, 37), and, 
therefore, represent three distinct pathways of myeioid differen- 
tiation. The expression of a substantial number of GM-CSF-R 
on mature DC (i.e., spleen DC as weU as d3 LC) also indi- 
cates a myeloid origin of DC,  as previous studies (43) have 
shown that essentially all cells within the myeloid lineage 
(monocytes, polymorphs, eosinophils) display GM-CSF-R 
whereas erythroid cells and lymphoid cells (except certain T 
cell lines  [27,  42])  are negative. 
GM-CSF induces the proliferation of DC precursors (37, 
44-47),  maintains DC viability (7, 8, 13, 48), and mediates 
the development from less mature but nonproliferating pre- 
cursors into fully mature DC  (7,  8).  To more fully under- 
stand these events it will clearly be important  to monitor 
the expression of GM-CSF-R including any changes in binding 
affinity and to analyze respective regulatory mechanisms (see 
below). 
Spleen DC and LC Lack Receptors  for M-CSE  We next 
studied a classical  marker for macrophages, i.e., the expres- 
sion of M-CSF-R.  Neither equilibrium binding (data not 
shown) nor cytofluorography analysis (using an anti-M-CSF-R 
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antibody kindly provided by Dr. R. E. Stanley) (Fig. 4) re- 
vealed any M-CSF-R on spleen DC or d3 LC. Ik,  ozptors were, 
as expected,  readily detectable  on peritoneal  macrophages 
('~30,000  receptors/eell).  Thymocytes lacked receptors for 
M-CSF  (negative control). 
The absence of M-CSF-R on mature DC is further proof 
that DC are not a specialized subset of macrophages, as the 
number of M-CSF-R increases on monocytes/macrophages 
with eeU maturation. For example, adherent  macrophages 
display 50,000  or more of these receptors  (43).  The lack 
of M-CSF binding sites also explains why LC (8,  15) and 
DC (Koch, F., unpublished observations) do not respond to 
M-CSF, and why the numbers of DC/I.C are virtually normal 
in osteopetrotic  mice (49, 50) that carry a defective M-CSF 
gene. 
Spleen DC and I.C, Express the High A.~nity Type I IL- 
1R.  IL-1  is known to enhance the function of skin (7), spleen 
(12), and thymic (51) DC, and to regulate the expression of 
GM-CSF receptors (52, 53). We, therefore, studied IL-1Rs 
on DC. Three complete equilibrium binding experiments with 
spleen DC and d3 LC prepared from BALB/c mice as well 
as control EL4-NOB1, and 70Z/3 cells were performed using 
human recombinant 12sI-IL-lcr  which binds to both type 
1 and type 2 murine IL-1R (32). Pilot experiments  using 
DC and d3 LC prepared from C3H/He mice gave comparable 
results. Scatchard analysis of the binding data revealed a single 
class of high affinity (Ka <100 pM) IL-1R on DC (mean 
69/ce11) as well as d3 LC (mean 490/ce11). The resuhs were 
comparable to EL4-NOB1 cdls (known to express the high- 
affinity type 1 IL-1R), but different from 70Z/3 cells (known 
to exhibit the 10-fold lower affinity type 2 IL-1R) (Fig. 5, 
Table 2). Pilot experiments employing human recombinant 
12sI-IL-1/~ also revealed a single class of IL-1 binding sites 
in similar numbers, but the Ka was somewhat lower ("~500 
pM). Preincubation of DC and LC in pH 3.0 glycine buffer 
to remove prebound IL-1 (31) did not significantly change 
Figure 5.  Equilibrium binding of rhu  lzsI-ILla.  Highly enriched 
BALB/c d3 I_C (A and A"),  spleen DC (B and B"),  and, as a control, 
EL4-NOB1 cells (known to express the high-affinity type 1 II.-1 R) (C 
and C') as well as 70Z/3 ceils (known to express the low-affinity type 
2 IblR) (/9 and D') were incubated for 2 h at 4~  with various concen- 
trations of rhu-Ibla (see Materials and Methods for experimental details). 
Panels A-D show specific binding data, panels A"-D" show a Scatchard 
representation of these data. Kd, dissociation constant, B max, maximum 
binding. Table  2.  Binding Characteristics of rhu 12sI-IL-lcr to Murine 
Cultured LC,  Spleen DC,  and Control Ceils 
Cell type  IL-1  Kd 
number/cell  pM 
d3  LC  490  (_+  20)  58  (_+  5) 
DC  69  (+  11)  85  (+  22) 
EL4-NOB1  2,150  (_+  40)  61  (_+  4) 
70Z/3  1,230  (_  240)  480  ( _+  132) 
Data represent the mean ( +  SD) of three independent equilibrium bind- 
ing assays performed as outlined under Materials and Methods. DC and 
LC were prepared from BALB/mice, but pilot exlxa'iments using C3H/He 
LC and DC yielded comparable results. 
the number of IL-1R.s detected. Human IL-1~3 as well as the 
human IL-1 receptor antagonist (hlL-lra) effectively com- 
peted  for  binding  of  125I-IL-lol to  spleen  DC  and  LC, 
demonstrating that the IL-1P,. on DC/LC can bind all three 
forms of IL-1 (Table 3). It is known that the IL-lra readily 
binds to the routine type 1 IL-1R yet only poorly, if at all, 
to the type 2 murine IL-1R (32,  54).  Blocking of lzsI-IL- 
1r  binding by hIL-lra is,  therefore,  further evidence  that 
DC/LC express the type 1 high-affinity IL-1R. Additional 
support was the finding that the antimurine type 1 IL-1R 
mAbs M15 (34) and 1593-01 (Genzyme Corp.) were able to 
completely block the binding of 12sI-IL-lc~ to spleen DC 
and LC (Table 3). Affinity cross-linking of lzSI-hlL-113 to IL- 
1R (33) revealed complexes of ,~100 kD which, upon sub- 
traction of ~18 kD for human IL-113, correspond to the ,~80 
kD molecular mass described for the type 1 IL-1R (but the 
complexes are distinctly larger than those produced by the 
60-kD type 2 IL-1R. of 70Z/3 cells [Hg. 6 A]). These data 
dearly show that d3 LC and spleen DC express high-affinity 
type 1 IL-1R. 
Table  3.  Effect  of rhu IL-1R Antagonist (IL-lra) and M15 
Antimurine Type I  IL-1R mAb on rhu ~2sI-IL-l~ Binding 
Percent  inhibition 
Cell type  IL-l-ra  M15  mAb 
DC  95-100  95-100 
d3  LC  95-100  90-100 
EL4-NOB1  96-100  96-100 
70Z/3  0-10  0-10 
The data (three experiments) are expressed as percent inhibition of rhu 
lZSI-IL-lot binding (at 3  x  10 -10 and 10 -9 M concentration with DC 
and LC, and 10 TM  to 10 -9 M concentration with cell lines) to 1.5  or 
2  x  106 cells in the presence of rhu IL-lra (300-fold  molar excess) or 
M15 mAb (50/~g/ml) when compared with the specific binding in the 
absence of inhibitor ( -  total binding of rhu lzsI-IL-lcx minus binding 
in the presence of 100-fold molar excess of rhu IL-18). For experimental 
details see Materials and Methods. 
Figure  6.  Characterization of IblK by a~nity cross-linking. Highly 
enriched BALB/c spleen DC (5  x  106), epidermal LC cultured for 1 d 
(m  LCdl)(2  x  106cells)and3d(-  I.~d3)(3  x  106inA,2  x  106 
in B) as well as EL4-NOB1 cells (5  x  10  ~) (~r  the murine type 
1 IL-1R.)  and 70Z/3 cells (5  x  106) (expressing the murine type 2 ID1R.) 
were cross-linked to rhu lz~I-IL-l~ in the absence (-) or presence (+) of 
50-fold molar excess of unlabeled Ibl, ~tracted, dectrophores~ (7.5% 
homogenous gel in A, 10-15% gradient gel in B), and autoradiographed 
as described in Materials and Methods. Note that LC and DC, like EL4- 
NOB1 cells, reveal complexes of "~100 kd that are distinctly larger than 
the complexes produced by the 70Z/3 cells, and that dl LC produce a 
more intense band than d3 LC. Lanes on the right and left side represent 
14C-labded molecular mass markers (code CF.756,  molecular mass from 
top to bottom 14.3, 21, 30, 46, 69, 97.4, and 200 kD; Amersham, Braun- 
schweig,  Germany). 
In pilot experiments we had been unable to detect specific 
binding of 125I-IL-lo~ to freshly prepared LC. This was not 
surprising given the protease sensitivity of the IL-1R mole- 
cules  (1%  trypsin  treatment  for  >--20 rain  removes  IL-1 
binding sites on cultured LC and EL4-NOB1 ceils, data not 
shown) and two sequential trypsin exposures during the LC 
enrichment  procedure (see Materials and Methods). We there- 
fore turned to cytofluorography analysis  with antitype 1 IL-1R 
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ment of LC. We prepared EC solely from cartilage-free thin 
dorsal ear halves, which allows preparation  of EC by mild 
trypsin exposure (0.4% for 15 rain). Using this protocol we 
found unequivocal staining of I.C (identified by their expres- 
sion of MHC class II molecules) with all three antitype 1 
II.,1R mAbs used (Fig. 7). Interestingly,  the keratinocytes, 
which in situ express mainly type 2 IL-1R mRNA (56), were 
not stained. These data suggest that freshly prepared LC (as 
in vitro equivalents of resident LC) express type 1 IL-1R's. 
We could not detect binding of antitype 1 IL-1R mAbs to 
either dl LC, d3 LC (expressing 500 IL-1R/cell, see above), 
or spleen DC (70 IL-1R/cdl). We suspect,  therefore,  that 
freshly prepared, immature I.C (as in vitro equivalents of LC 
in situ) express large numbers of type 1 IL-1Rs that are down- 
regulated upon culture and development  into fully mature 
DC. This notion is also supported by our preliminary finding 
(only one experiment as it is particularly demanding to pu- 
rify sufficient numbers of dl LC) that dl LC as shown by 
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Figure 7.  Cytofluorography analysis of type I IL,1K expression. Dot 
plot representation of ILIR type 1 staining ( =  fluorescence 1 on horizontal 
axis) of EL4-NOB1 cells and freshly prepared BALB/c epidermal cells using 
the anti-IblR type 1 mAb M15 (34). Staining with two other anti-IblR 
type 1 mAbs (mAb 1593-01 [obtained from Genzyme Corp.] as well as 
mAb M5 [34]) yidded comparable results with BALB/c as well as C3H/He 
epidermal cells. EL4-NOB1 cells (B), which express the type 1 ID1R (,,~2140 
per cell) have been shown to be stained by the anfi-IL-1R type 1 mAb 
M15 (55).  Fresh LC (A), identified by staining their MHC class II an- 
tigens (=  fluorescence 2 on vertical axis), are dearly stained above bach 
ground (isotype control). MHC class II negative epidermal cells (primarily 
keratinocytes),  do not stain above background. 10,000 viable, propidinm 
iodide negative cells were evaluated. 
equilibrium binding analysis express at least 1,200 IL-LR, i.e., 
2.5 times the number found on d31.13, and upon affinity-cross- 
linking produce a more intense band relative to d3 1(2 (Fig. 
6 B). 
The expression of high-affinity type I II.-1R by DC might 
be important for the regulation of their development and matu- 
ration (see discussion below), and also further supports  the 
notion that dendritic cells are distinct from monocytes/mac- 
rophages which typically express the lower affinity type 2 
IbaR (31). 
Possible Relevance of Differential Cytokine Receptor Expres- 
sion on DC.  As outlined in the introduction it has been 
known for some time that GM-CSF (7, 8, 13) and IL-1 (7, 
12) have profound effects on LC and spleen DC, whereas 
M-CSF (8, 15) does not seem to affect these cells. It is also 
well established that cytokine receptor expression controls 
target cell responsiveness and thus affects the biological net 
effect of cytokines. However, there has been no information 
on the expression of cytokine receptors  on DC, likely be- 
cause it is difficult and costly to purify sufficient numbers 
of these trace cell populations.  Our experiments provide data 
on cytokine receptors and (a) support the notion that DC 
represent a distinct mydoid subset plus (b) provide clues to 
the mechanism and regulation of DC maturation and devel- 
opment. Freshly isolated LC (as equivalents of resident 1.(2) 
develop into fully mature (i.e., potent immunostimulatory) 
DC upon culture in the presence of GM-CSF, whereas IL-1 
has an enhancing effect but is not essential (7, 8, 57). In vivo, 
the intradermal injection of even large doses of GM-CSF has, 
however, quite surprisingly no discernible effect on resident 
LC (Koch, F., unpublished results),  whereas IL-1 upon in- 
tradermal injection induces LC maturation as first observed 
by Nylander Lundqvist et al. (5) and more recently studied 
in more detail by Enk et al. (6). These discrepant findings 
can be reconciled, however, in a working model that takes 
into account the ample expression of type 1 IL-1Rs on im- 
mature LC reported here as well as the observation that IL-1 
can upregulate the B subunit of the GM-CSF-R (52, 53). 
We suggest that IL-1 (released in situ from keratinocytes [IL- 
lc~] and/or LC [IL-1B] upon deposition of antigen [58] or 
in vitro during preparation  of epidermal cells and isolation 
of LC [16, 59, 60]) mediates the upregulation of GM-CSF 
receptors on epidermal I.(2 (i.e., immature DC) by interacting 
with their type 1 IL-1R, and hereby induces the GM-CSF-de- 
pendent maturation of 1/2 (7, 8) (and possibly of other im- 
mature DC as well). The proposal that IL-1 regulates DC 
function at the level of the GM-CSF-R may also explain prior 
experiments  that IL-1 boosts DC function (12). 
Our finding that mature LC/DC express a single class of 
intermediate-affinity GM-CSF-R is in concordance with such 
a model. Recent progress in elucidating the molecular basis 
of GM-CSF-R has revealed, that binding affinities reflect the 
different relative numbers of GM-CSF-R c~ and B chains. Park 
et al. (61) showed that COS cells that express solely the ol 
subunit of the routine GM-CSF-R exhibit low-affinity binding 
(Kd >10,000  pM), whereas coexpression of the/~ subunit 
produces a subpopulation of high-affinity GM-CSF binding 
1773  K~apgen et ~. sites.  Interestingly,  Budel et al.  (62) recently demonstrated 
in the human system that upon myeloid maturation and up- 
regulation of the fl subunit the high at~nity (Ka "~50 pM) 
converted into  intermediate  aflfinity GM-CSF binding  (Kd 
"~300-700 pM). Using COS cell transfection it was proven 
that overexpression of the ~ chains relative to the GM-CSF-Rce 
subunits indeed causes a change from high to intermediate 
affinity binding.  In view of these findings it is,  of course, 
tempting to speculate that our observation of a single class 
of intermediate affinity GM-CSF-R on mature DC (i.e., spleen 
DC and cultured LC) is due to a high B to ce subunit ratio 
possibly as a result of a marked upregulation of the fl subunit 
during  the  development  of less  mature,  nonproliferating 
precursors into  fully mature DC. 
GM-CSF has more recently also been shown to support 
in vitro the development of murine DC from MHC class 
II negative to more committed, rapidly proliferating, MHC 
class II positive precursors that finally give rise to fully ma- 
ture, nondividing DC (36, 44, 46).  It will, therefore,  also 
be of interest to study whether IL-1 and/or other cytokines 
regulate GM-CSF-R expression during  growth,  as well as 
maturation  of DC progenitors. 
In summary, our data (a) provide further evidence that DC 
represent a distinct subset of the myeloid lineage;  and (b) sug- 
gest that IL-1 regulates DC function by upregnlating GM- 
CSF receptors, and thereby, the established responsiveness of 
DC to GM-CSF for growth, viability, and function. Further 
studies of cytokine receptors are likely to be critical to fully 
understand the control of DC growth and maturation,  and 
might also allow the design of protocols for modulating these 
processes in clinical  situations. 
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